Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases Giuseppe BroggiFrancesca GiannoManila Antonelli Topic Review 25 February 2022 Pages: 1 - 14
Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma Rui LinYimin XuYawei Liu Laboratory Investigation 21 February 2022 Pages: 15 - 26
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study Daniel Antunes MorenoLuciane Sussuchi da SilvaRui Manuel Reis Laboratory Investigation 15 February 2022 Pages: 27 - 35
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies Denise ObrechtMartin MynarekStefan Rutkowski Clinical Study Open access 21 February 2022 Pages: 37 - 48
Eigenvector PageRank difference as a measure to reveal topological characteristics of the brain connectome for neurosurgery Onur TanglayIsabella M. YoungMichael E. Sughrue Clinical Study 04 February 2022 Pages: 49 - 61
Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases Oz HaimShani AbramovRachel Grossman Clinical Study 04 February 2022 Pages: 63 - 69
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018 Mirketa MarkuBirthe Krogh RasmussenPernille Envold Bidstrup Clinical Study 28 January 2022 Pages: 71 - 80
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases Maria DiazPriya SinghElena Pentsova Clinical Study 03 February 2022 Pages: 81 - 90
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience Bryan J. NethSamantha N. BalakrishnanMichael W. Ruff Clinical Study 25 January 2022 Pages: 91 - 100
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases Mohammed AbdulhaleemHannah JohnstonMichael D. Chan Clinical Study 15 February 2022 Pages: 101 - 107
Frameless robot-assisted stereotactic biopsies for lesions of the brainstem—a series of 103 consecutive biopsies Iulia Peciu-FlorianuVictor LegrandNicolas Reyns Clinical Study 27 January 2022 Pages: 109 - 119
Stereotactic radiosurgery versus active surveillance for incidental, convexity meningiomas: a matched cohort analysis from the IMPASSE study Stylianos PikisGeorgios MantziarisJason Sheehan Clinical Study 29 January 2022 Pages: 121 - 128
Effects of sleep disturbance on neuropsychological functioning in patients with pediatric brain tumor Jenna A. ChiangPaulina T. FeghaliAshley M. Whitaker Clinical Study 29 January 2022 Pages: 129 - 135
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma Waqar HaqueCaitlyn TehBin S. Teh Clinical Study 01 February 2022 Pages: 137 - 146
Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites Palma Solano-PáezAdriana FonsecaEric Bouffet Clinical Study 05 February 2022 Pages: 147 - 156
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value? Kaiyun YangAlexander P. LandryPaul N. Kongkham Clinical Study 29 January 2022 Pages: 157 - 163
Predictors of hearing functional outcome following surgery for cerebellopontine angle meningioma Nida FatimaAnne K. MaxwellGregory P. Lekovic Clinical Study 03 February 2022 Pages: 165 - 176
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study Andres Ramos-FresnedoMichael W. PullenWendy J. Sherman Clinical Study 17 February 2022 Pages: 177 - 185
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review Dayton GroganDavid P. BrayKimberly B. Hoang Clinical Study 25 February 2022 Pages: 187 - 195
Trends in radiation dose for low grade gliomas across the United States Emma ByrneStephen AbelRodney E. Wegner Clinical Study 23 February 2022 Pages: 197 - 205
